simulating dissolution data beyond observed lab data [Dissolution / BCS / IVIVC]

posted by dshah  – India, 2024-06-10 11:10 (389 d 04:45 ago) – Posting: # 24027
Views: 2,620

Hi Achievwin,

I agree with Helmut's input.
Further- the assumptions used for extrapolation of modeling, the function/model used used for extrapolation, limitation of used model can be considered on a brief.
Generally, dissolution condition which can fasten the rate of release can be tried for e.g. increasing temperature, rpm, change over media, etc. so that it can be confirmed that the drug release is complete.

Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
84 visitors (0 registered, 84 guests [including 47 identified bots]).
Forum time: 15:56 CEST (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5